These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 20964806

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Prediction of tyrosinase inhibition activity using atom-based bilinear indices.
    Marrero-Ponce Y, Khan MT, Casañola Martín GM, Ather A, Sultankhodzhaev MN, Torrens F, Rotondo R.
    ChemMedChem; 2007 Apr; 2(4):449-78. PubMed ID: 17366651
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Bond-based 2D TOMOCOMD-CARDD approach for drug discovery: aiding decision-making in 'in silico' selection of new lead tyrosinase inhibitors.
    Marrero-Ponce Y, Khan MT, Casañola-Martín GM, Ather A, Sultankhodzhaev MN, García-Domenech R, Torrens F, Rotondo R.
    J Comput Aided Mol Des; 2007 Apr; 21(4):167-88. PubMed ID: 17333484
    [Abstract] [Full Text] [Related]

  • 8. New tyrosinase inhibitors selected by atomic linear indices-based classification models.
    Casañola-Martín GM, Khan MT, Marrero-Ponce Y, Ather A, Sultankhodzhaev MN, Torrens F.
    Bioorg Med Chem Lett; 2006 Jan 15; 16(2):324-30. PubMed ID: 16275084
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discovery of novel anti-inflammatory drug-like compounds by aligning in silico and in vivo screening: the nitroindazolinone chemotype.
    Marrero-Ponce Y, Siverio-Mota D, Gálvez-Llompart M, Recio MC, Giner RM, García-Domènech R, Torrens F, Arán VJ, Cordero-Maldonado ML, Esguera CV, de Witte PA, Crawford AD.
    Eur J Med Chem; 2011 Dec 15; 46(12):5736-53. PubMed ID: 22000935
    [Abstract] [Full Text] [Related]

  • 11. Vanilloid derivatives as tyrosinase inhibitors driven by virtual screening-based QSAR models.
    Rescigno A, Casañola-Martin GM, Sanjust E, Zucca P, Marrero-Ponce Y.
    Drug Test Anal; 2011 Mar 15; 3(3):176-81. PubMed ID: 21125547
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Computational discovery of novel trypanosomicidal drug-like chemicals by using bond-based non-stochastic and stochastic quadratic maps and linear discriminant analysis.
    Castillo-Garit JA, Vega MC, Rolon M, Marrero-Ponce Y, Kouznetsov VV, Torres DF, Gómez-Barrio A, Bello AA, Montero A, Torrens F, Pérez-Giménez F.
    Eur J Pharm Sci; 2010 Jan 31; 39(1-3):30-6. PubMed ID: 19854271
    [Abstract] [Full Text] [Related]

  • 16. Comparative QSAR studies of CYP1A2 inhibitor flavonoids using 2D and 3D descriptors.
    Roy K, Roy PP.
    Chem Biol Drug Des; 2008 Nov 31; 72(5):370-82. PubMed ID: 19012573
    [Abstract] [Full Text] [Related]

  • 17. 3D-QSAR and molecular docking studies of benzaldehyde thiosemicarbazone, benzaldehyde, benzoic acid, and their derivatives as phenoloxidase inhibitors.
    Xue CB, Zhang L, Luo WC, Xie XY, Jiang L, Xiao T.
    Bioorg Med Chem; 2007 Mar 01; 15(5):2006-15. PubMed ID: 17258462
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.